By Sindhu Sundar ( January 20, 2015, 9:45 PM EST) -- The U.S. Supreme Court's decision Tuesday not to review a challenge by generics makers including Teva Pharmaceuticals USA Inc. to failure-to-update labeling claims effectively puts the future of such suits in the hands of the U.S. Food and Drug Administration, which is considering a plan to allow generics makers to update labels, attorneys say....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.